TrialJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2019

An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB).

Margaret Rosenfeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.